Long-term safety and efficacy of ziv-aflibercept in retinal diseases
Author:
Publisher
BMJ
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference21 articles.
1. Comparison of aflibercept, bevacizumab, and ranibizumab for treatment of diabetic macular edema: extrapolation of data to clinical practice;Heier;JAMA Ophthalmol,2016
2. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies;Schmidt-Erfurth;Ophthalmology,2014
3. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study;Heier;Ophthalmology,2014
4. Preclinical investigations of intravitreal ziv-aflibercept;de Oliveira Dias;Ophthalmic Surg Lasers Imaging Retina,2014
5. Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture;Malik;Br J Ophthalmol,2014
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An In-vitro Evaluation of a New Approach in AMD: Effects of the Combination of Resveratrol and Anti- VEGFs on ARPE-19 Cells;2024-08-22
2. Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection;BMC Ophthalmology;2022-06-29
3. The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration;Scientific Reports;2022-02-22
4. Comparison of Loading Doses of Ziv-Aflibercept and Aflibercept in Neovascular Age-Related Macular Degeneration;Asia-Pacific Journal of Ophthalmology;2020-03
5. In vitro response and gene expression of human retinal Müller cells treated with different anti-VEGF drugs;Experimental Eye Research;2020-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3